Dr. James McCaffrey presents a complete end-to-end demonstration of anomaly detection using k-means data clustering, ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
Who’s interested in a brand new, from-scratch boundary representation (BREP) kernel? How about one that has no topological naming problem, a web-native parametric CAD front end to play with, ...
Americans change jobs an average of every four years. Onboarding with your new employer provides a lot of opportunity to forget about an old retirement account from your old company. While 401(k)s ...
Our phones help us keep in touch with people, manage our schedules, make payments, listen to music, work, store photos and videos, and more. For these reasons, losing or misplacing your phone can be a ...
Hi there—I’m Debra Ellis, and I believe healing begins with connection, compassion, and a good dose of humor. With over 30 years of experience in behavioral health, social work, and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results